Investigation of Heart Failure Status Over Time Using Respiratory Parameters

ResMed50 enrolled

Overview

The purpose of the study is to investigate respiratory indicators for clinically important changes in Heart Failure status over time.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Heart Failure, Congestive Sleep Apnea Syndromes

Interventions

ApneaLinkDEVICE

A two channel sleep screening device for the assessment of Sleep Disordered Breathing.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Moderate to severe Heart Failure (as determined by Echocardiogram or by treating physician) Exclusion Criteria: * Malignant disease affecting gas exchange or respiratory parameters * Medications compromising breathing with no adverse affects on heart failure * Clinically significant (moderate to severe) asthma requiring therapy * Chronic parenchymal lung disease (FEV1/FVC ratio = 65% or as determined by the treating physician) * Severe pulmonary hypertension * Heart failure due to alcohol abuse or chemotherapy * Narcotic abuse/intravenous drug use (including HIV+ and hepatitis C) * Alcohol consumption \> 80g/day * Patients receiving home Oxygen * Methicillin- resistant Staphylococcus aureus infection * Narcolepsy * Cataplexy * Enrolled in any concurrent study, that may confound the results of this study. * Inability or refusal to sign the Patient Consent Form * Inability or refusal to adhere to protocol requirements

Locations (1)

Royal Prince Alfred Hospital

Camperdown, New South Wales, Australia

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.